2019 Cannabis Business Award's Publication of the Year |
WEDNESDAY, SEPTEMBER 6, 2023 |
FMCPG HAS BEEN SERVING THE PHYSICAN COMMUNITY
SINCE 2020 |
REGISTER FOR TONIGHT'S MEETING WEDNESDAY, SEPTEMBER 6, 2023 AT 6:30PM THE "FLORIDA MEDICAL CANNABIS PHYSICIAN GROUP" (FMCPG)
FOR ALL "MEDICAL MARIJUANA DOCTORS" AND "MMTC DIRECTORS ONLY " TOPICS TO BE DISCUSSED THIS YEAR LEGISLATIVE PRIORITIES FOR TALLAHASSEE
PRESENTATION BY JEFFREY BLOCK, M.D. ABOUT THE RECLASSIFICATION OF CANNABIS DISCUSSION ABOUT THE FEDERAL RECLASSIFCATION OF CANNABIS TO A SCHEDULE III DRUG "EFFECT ON PATIENTS, YOUR PRACTICE AND MMTC'S" FROM THE WASHINGTON POST
"If a recommendation by the nation’s top health agency to reclassify marijuana is adopted, the drug could gain wider acceptance as a medical treatment, pot businesses could see their bottom line boosted and a path toward national legalization could be charted" PROTECTING YOUR MEDICAL CANNABIS PRACTICE
Updates on RFE Requests Becoming a Chapter of the Society of Cannabis Clinicians
QUESTIONS FROM PHYSICIANS HOW TO BEST ANSWER YOUR PATIENT QUESTIONS |
MEDICAL CANNABIS PHYSICIAN
PROMOTION PACKAGE BY CANNABIS NEWS FLORIDA ARTICLE: Physician will contribute an article of 350 words**. This article will appear in the Cannabis News Florida e-newsletter for one month (4 weeks).
E-MAIL BLAST: Cannabis News Florida will send out one e-mail blast promoting the Physician to the other physicians in three zip code areas or one city to be determined by the Physician. The Physician will supply the information for the email blast. The Article above can be used in the e-mail blast.
The cost of this program is ONLY $500.
**Cannabis News Florida will assign a writer for a telephone interview with the Physician and create the article to be published. Physician shall have the right to review and approve the article before publication for an additional cost of $100.
IF YOU ARE INTERESTED, PLEASE EMAIL ME AT CHARLES@CANNABISNEWSFLORIDA.COM OR CALL MY CELL AT 954-605-4785 |
NEWS FROM THE PAST WEEK
RELATING TO THE BUSINESS OF MMTC'S IN FLORIDA Click on Company Logo to be Transferred to Web Site |
GOLDLEAF is a Cannabis 2.0 company. By this we mean that the company was founded by three partners who have already built some of the most successful cultivation, manufacturing, and retail cannabis businesses in the country and are now bringing that passion and expertise together to create something the cannabis market has never seen!
We are excited to offer our patients a luxury experience while distributing the highest quality medical cannabis for the most affordable price in an ethical way. From curiosity to consumption, we strive to give our patients a seamless, luxurious, unique and memorable experience. Our service comes second to none- from placing a delivery order to an in-store shopping experience our customer service and care are of utmost importance.
Our team of legacy growers are steeped in knowledge, with decades of collective experience. By implementing a variety of cultivation techniques our growers maximize the potential of each particular strain. GOLDLEAF takes pride in our conscious cultivation. Our primary brand partner Ideal Cannabis uses organic living soil, live microorganisms for pest control, and is manatee safe with minimal drain waste. Bringing on the best brand partners in the industry, we strive to provide access to new varieties of strains to make sure there is something for all of our valued patients.
GOLDLEAF currently offers an exemplary delivery service to our patients! Our team is more than happy to deliver orders meeting our minimum requirement straight to your doorstep for no extra charge! We plan on continuing to expand to eventually deliver statewide. We have a team of delivery coordinators available to answer any questions you have any day between 7am-9pm. Delivering in either a Tesla or Lexus, we hope to further our eco-consciousness utilizing a fleet of electric and hybrid vehicles.
Our first store front is now open in Sebring, FL. At GOLDLEAF, we believe that no detail is too small when it comes to providing 5-star service. All the services we provide are designed to create a luxurious and comfortable environment for patients, making the experience of purchasing cannabis as enjoyable and stress-free as possible. Being highly knowledgeable and attentive, our staff strives to ensure that every patient feels seen, heard, and valued with confidence that their unique needs and concerns are thoroughly addressed. We believe the atmosphere in which you experience our products is just as important as the products themselves. From the moment you enter, you will be immersed in a seamless environment where every detail, from the imported finishes to the cutting-edge technology, has been carefully curated to reflect the luxury and sophistication that defines the GOLDLEAF brand. GOLDLEAF is the ultimate medical cannabis experience.
|
GREEN THUMB INDUSTRIES ANNOUNCES SHARE REPURCHASE PROGRAM
CHICAGO and VANCOUVER, British Columbia, Sept. 05, 2023 – Green Thumb Industries Inc. (“Green Thumb” or “the Company”) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced that its Board of Directors has authorized the repurchase pursuant to a normal course issuer bid, of up to 10,486,951 of its Subordinate Voting Shares (“Shares”) (up to 5% of the class) from time to time over a 12-month period. The Board of Directors authorized the Company to spend up to USD $50 million for the repurchase program.
“We believe instituting a share repurchase program is an appropriate tool for creating shareholder value without compromising our growth initiatives. This action was in the works before last week’s announcement from the U.S. Department of Health and Human Services, which called for cannabis to be reclassified to Schedule III. Having witnessed a 30-plus percent move in the sector based on news from Washington, D.C., we want the ability to take advantage for shareholders should the opportunity arise,” said Green Thumb Founder, Chairman and Chief Executive Officer Ben Kovler.
READ MORE |
NEW NAME HOUSE OF PLATINUM CANNABIS |
NATIONAL AND INTERNATIONAL NEWS |
RAMM PHARMA CORP. ANNOUNCES NON-BROKERED PRIVATE PLACEMENT AND INTENTION TO COMMENCE NORMAL COURSE ISSUER BID
TORONTO, Sept. 05, 2023 — RAMM Pharma Corp. (including its wholly owned subsidiaries, the “Company” or “RAMM”) (CSE: RAMM), announces that it intends to complete a non-brokered private placement of up to 20,000,000 units (the “Units“) of the Company at a price of $0.05 per Unit for total gross proceeds of up to $1,000,000 (the “Offering“). Each Unit shall be comprised of one common share in the capital of the Company (each, a “Common Share”), and one Common Share purchase warrant (each a “Warrant”), with each Warrant entitling the holder thereof to acquire one Common Share at a price of $0.05 for a period of 36 months following the closing date of the Offering. The proceeds from the Offering are expected to be used for working capital and general corporate purposes. The Offering is expected to close on or about September 26, 2023.
Ramm also announces its intention to commence a normal course issuer bid (the “NCIB”), under which it may purchase up to 5% of the current number of issued and outstanding Common Shares. The NCIB may commence on or about September 5, 2023 and shall expire on the 12-month anniversary of the effective date of the NCIB. All Common Shares purchased under the NCIB will be purchased on the open market through the facilities of the Canadian Securities Exchange (the “CSE”). The Company has appointed Clarus Securities Inc. to co-ordinate and facilitate the NCIB purchases. All purchases made under the NCIB will be at the prevailing market price for such Common Shares on the CSE at the time of purchase, and shall be duly cancelled and returned to treasury. The Company has implemented the NCIB should it view the market price for its Common Shares to not adequately reflect the value of the Company.
READ MORE |
CANOPY GROWTH SHOWCASES POWER OF BRANDS WITH INDUSTRY AWARDS
Tweed nominated for Karma Cup and Grow Up Awards; Wana a finalist for Grow Up Award
SMITHS FALLS, ON, AUGUST 30, 2023 – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a world-leading diversified cannabis company, today announced that two of the Company’s brands in the Canadian adult-use market have been recognized as finalists for prestigious industry awards.
Illustrating the impact of an impressive brand evolution, Tweed’s Kush Mints has been nominated for a 2023 Karma Cup in the Hybrid Flower category, as it has demonstrated its consumer appeal with Tweed Kush Mints 28g being the fourth best performing flower SKU in Canada in Q1 FY2024[1]. Celebrating cannabis innovation, creativity, and quality, the Karma Cup Awards recognized Tweed’s Kush Mints for its unique cross between Animal Mints and Bubble Kush. Sourced from a private library and demonstrating Tweed’s commitment to flower innovation, Kush Mints boasts a high terpene content near 2.5% — setting it apart from the competition — and has driven 73% of the 28g segment’s growth nationally in the first three months of 2023.
READ MORE |
OPTIMI HEALTH ANNOUNCES SECOND TRANCHE OF CAD $1,000,000 SECURED FOR DEBT FINANCING
VANCOUVER, British Columbia, Sept. 05, 2023 — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi Health” or the “Company”), a Canadian drug research and formulation company licensed by Health Canada to manufacture psychedelic substances such as MDMA and high-quality, GMP-grade natural psilocybin, is pleased to announce it has entered into a non-dilutive Debt Financing Agreement (“DFA”) and General Security Agreement (“GSA”) for total proceeds of CAD$1,000,000 (the “Loan”) from two arm’s length parties (collectively the “Lender”).
READ MORE |
22ND CENTURY GROUP INITIATES STRATEGIC ALTERNATIVES PROCESS FOR ITS TOBACCO ASSETS
BUFFALO, N.Y., Sept. 05, 2023 — 22nd Century Group, Inc. (NASDAQ: XXII) (the “Company”) today announced that its Board of Directors, after consultation with its financial and legal advisors, has initiated a process to evaluate strategic alternatives with respect to the Company’s tobacco assets. The process will include consideration of a range of strategic, operational and financial transactions and alternatives, such as business combinations, asset sales, licensing agreements, alternate financing strategies and other options.
“We believe the current market capitalization of the Company does not appropriately reflect the value of our assets or their long-term potential. After extensive discussion, our Board has determined that the best way to maximize value for shareholders is to comprehensively evaluate the Company’s strategic alternatives,” said Nora Sullivan, Chair of the Board of 22nd Century. “Through the strategic alternatives process, we hope to identify ways to monetize the value or more effectively expand the market reach of our tobacco portfolio, including our innovative VLN tobacco harm reduction products, the first and only combustible tobacco product to receive a Modified Risk Tobacco Product designation from the U.S. Food and Drug Administration.”
READ MORE |
RIFF CANNABIS LAUNCHES NEW DIAMOND INFUSED PRE-ROLLS AND BLUNTS
The New Hand-Crafted RIFF Diamond Infused Pre-rolls and Blunts Are Now Available in Ontario
PURE ‘DIAMONDS COLLECTION’ IS ‘A CUT ABOVE’
TORONTO, Aug. 30, 2023– Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a leading global cannabis and consumer packaged goods company, today debuts its new ‘Diamonds Collection’ by its Premium cannabis lifestyle brand RIFF. Introducing its new Diamond Infused Pre-rolls, including Melonaide and Purple Punch OG strains, and ’26 Delta Diamond Infused Blunts featuring Blue CKS featuring Girl Scout Cookies (GSC) lineage and Blueberry Kush, both produced with small-batch, hand-crafted whole flower boosted by THCA diamonds and premium full spectrum resin. With a rich blend of terpenes and cannabinoids made to deliver an ultra-potent kick, the new diamonds collection takes consumers to new heights, unlike anything the brand has offered before.
RIFF’s Diamond-Infused Pre-rolls:
The new diamond-infused pre-rolls come in two powerful small-batch craft flower offerings including its popular Melonaide flower, and the brand’s new Purple Punch OG flower. RIFF’s new diamond-infused pre-rolls are produced with THCA diamonds, feature full-spectrum resin, are wrapped in premium paper, and are rolled in kief.
READ MORE |
AWARD WINNING CANNABIS CONSULTING FIRM SIVA ENTERPRISES ANNOUNCES SHIFT IN STRATEGIC FOCUS TO DISTRESSED ASSETS AND CORPORATE TURN AROUNDS IN THE CANNABIS INDUSTRY
SIVA To Release Highly Anticipated Special Report on the State of the Cannabis Industry
LOS ANGELES, Aug. 29, 2023 — SIVA Enterprises Inc. (SIVA), a nationally acclaimed cannabis consulting firm, announced a strategic shift in its focus towards distressed assets and turnarounds. With a distinguished track record and a deep understanding of the nuances of the cannabis industry, SIVA is poised to lead the way in revitalizing struggling businesses and navigating the challenges of a rapidly changing market.
Prior to the Covid 19 pandemic, the cannabis industry saw aggressive growth and expansion. Post pandemic, the industry has become fragmented and highly volatile. SIVA CEO and cannabis industry expert, Avis Bulbulyan, stated “There is a major disconnect amongst the different sectors and stakeholders. Businesses are failing, industry associations are folding, and sound policy has taken a back seat to politics.”
READ MORE |
BELOW ARE THE LINKS TO THE DIRECTORY OF FLORIDA CANNABIS DOCTORS AND DISPENSARIES IN THE STATE OF FLORIDA |
QUALIFIED PATIENTS OVER 842,000 AND 587 DISPENSING LOCATIONS
|
LATEST OMMU REPORTS FROM OFFICE OF MEDICAL MARIJUANA USE IN THE STATE OF FLORIDA Highlights from
SEPTEMBER 1, 2023 Report
BY THE NUMBERS Qualified Patients: (Active ID Card):
SEPT 1 2023 - 842,512 AUG 25 2023- 841,580 AUG 18 2023- 840,041
AUG 11 2023- 838,470 AUG 4 2023- 837,122 Patients Last Week: 932
Qualified Ordering Physicians: 2,633
New Doctors Last Week: 6 Reporting Period: AUG 25 TO AUG 31 2023 Amount of Medical Marijuana Dispensed - (mgs THC) 340,114,995
Amount of Low-THC Cannabis Dispensed - (mgs CBD) 3,228,060
Amount of Marijuana in a From for Smoking (oz) 109,019.709 Approved Dispensing Locations: 587 ADD LAST WEEK - LESS 1
SURTERRA WELLNESS - LESS 1 |
UPCOMING MEETING AND CONFERENCES |
IT'S TIME TO SHOW THE HEALTHCARE COMMUNITY HOW YOU HELP THEIR PATIENTS
PARTICIPATE IN SFHHA ANNUAL GOLF TOURNAMENT |
ADVERTISEMENT OPPORTUNITIES
If your goal is to get your business in front of the right people in the cannabis industry or you want to be an integral part of this new and exciting business opportunity, then you need to join with Cannabis News Florida as we help to establish cannabis as a major part of the economy in Florida. Cannabis News Florida is an online publication focusing on both local and national news from leading authorities about the medical and business developments in the medical cannabis industry covering the entire state of Florida.
Join the Cannabis News Florida force online and in print. We offer several marketing options to fit all budgets:
· MMTC PROMOS LISTED IN EACH E-NEWSLETTER
• Directory Listing
• Banner Ads
• Ad Space in the Newspaper
• Feature Articles
• Weekly Newsletters
For further information or to make your ad reservation, please call:561-368-6950 / 954-605-4785 cell charles@cannabisnewsflorida.com
|
|
|